The primary objective of this study is to determine whether rosuvastatin reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction (MI) or non-fatal stroke (time to first event).
The secondary objectives are to evaluate the effects of rosuvastatin on:
(and 3 more...)
60 Years and older (Adult, Senior)
4522IL/0098 D3562C00098 CORONA
September 21, 2005
November 19, 2010
Research Site Aalst, Belgium
Research Site Bouge, Belgium
Research Site Brugge, Belgium
(and 375 more...)
† Study has passed its completion date and status has not been verified in more than two years.